Advertisement

Topics

The Bachmann-Strauss Dystonia and Parkinson Foundation Company Profile

15:46 EDT 23rd September 2018 | BioPortfolio

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to provide medical and patient information. Lou Bachmann (1916-2000) and Bonnie Strauss founded The Bachmann-Strauss Dystonia & Parkinson Foundation (BSDPF) in 1995 as a nonprofit 501(c)3. The Foundation was started to encourage new scientific research in the fields of dystonia and Parkinson's disease and to heighten awareness about the diseases. The Foundation is also the leading organization actively looking at the interface between dystonia and Parkinson’s disease. Early stages of scientific research are often the hardest to fund. Following a similar concept to that of a "venture capital" fund, seed money is funded through annual grants, which help to leverage new ideas and advances in the fields. To date, the Foundation has raised over $35 million dollars and funded 235 grants in the U.S. and abroad.


News Articles [993 Associated News Articles listed on BioPortfolio]

The Michael J. Fox Foundation Launches Parkinson’s Clinical Trial Platform

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched an educational suite dubbed the “Parkinson’s Clinical Trial Companion.”

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson’s Pro...

Bachmann Welser Capital Group concede empréstimo não colaterizado a projetos através da ...

LONDRES, 2 de abril de 2018 /PRNewswire/ -- O Bachmann & Welser Capital Group é um grupo independente, reconhecido e bem financiado que proporciona monetização Read more...

New €10 million Parkinson's study

(University of Bristol) A new €10 million international trial to evaluate a new model of care that aims to improve the quality of life for people living with Parkinson's disease will be conducted wit...

Bachmann Welser Capital Group proporciona préstamo sin aval para proyectos mediante la ...

LONDRES, 2 de abril de 2018 /PRNewswire/ -- Bachmann & Welser Capital Group es un grupo establecido, independiente y bien financiado que monetiza cartas de Read more...

The Michael J. Fox Foundation for Parkinson's Research Announces Availability of $7 Million in ...

The programs opening today aim to use novel technologies to treat one of Parkinson's most serious symptoms; increase understanding and development of two leading drug Read more...

The Silverstein Foundation for Parkinson’s with GBA and The Michael J. Fox Foundation for Parkinson’s Research Hold Workshop to Accelerate GBA Therapeutic Development

The Silverstein Foundation for Parkinson’s with GBA and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) held a workshop yesterday to discuss accelerating therape...

Drugs and Medications [824 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [926 Associated PubMed Articles listed on BioPortfolio]

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Off state toe dystonia (TD) is a symptom frequently encountered in Parkinson's disease (PD), but little is known about its evolution after subthalamic nucleus deep brain stimulation (STN-DBS).

Simultaneous treatment of epilepsy and secondary dystonia after anterior temporal lobectomy and amygdalohippocampectomy.

The relationship between temporal lobe epilepsy and focal limb dystonia is a well-recognized phenomenon, yet its pathogenesis and anatomical foundation are not well understood. Here, we describe two p...

Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia.

Adult onset laryngeal dystonia (LD) can be isolated or can be associated to dystonia in other body parts. Combined forms can be segmental at the onset or can result from dystonia spread to or from lar...

Phenytoin induced dystonia.

Acar T, Alkan G, Çaksen H, Ertekin B, Ergin M, Koçak S, Cander B. Phenytoin induced dystonia. Turk J Pediatr 2018; 60: 111-112. The abnormalities of dopaminergic activity in the basal ganglia have b...

Dystonia as a network disorder: a concept in evolution.

This survey takes into consideration the most recent advances in both human degenerative ataxias, disorders with a well established cerebellar origin, and discoveries from dystonia rodent models aimed...

Clinical Trials [1536 Associated Clinical Trials listed on BioPortfolio]

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

This study occurs during five visits that are already scheduled as part of "Biomarkers to Guide Directional DBS for Parkinson's Disease" (ClinicalTrials.gov Identifier: NCT03353688). If pa...

Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia

In this study, we will determine if posture and heart rate variability will significantly improve in Parkinsons disease with camptocormia after osteopathic manual treatments dystonia.

DBS in the Treatment of Intractable Movement Disorders

The aim of this study is to observe the efficacy of Deep Brain Stimulation in the treatment of Parkinson's disease,Essential Tremors and Dystonia in our locality.

Humanitarian Device Exemption

The purpose of this study is to allow patients to undergo deep brain stimulation (DBS) surgery for the treatment of dystonia. This is NOT a research study, but rather, a requirement by th...

Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome

The purpose of this study is to determine whether Mepolizumab (a monoclonal antibody against interleukin-5) is a safe and well-tolerated therapy that will allow for steroid tapering in pat...

Companies [1513 Associated Companies listed on BioPortfolio]

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to...

Levi Strauss & Co.

Levi Strauss & Co. is one of the world’s largest branded apparel companies and the global leader in jeanswear, marketing its products in more than 110 countries worldwide. Th...

Dystonia Medical Research Foundation

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

More Information about "The Bachmann-Strauss Dystonia and Parkinson Foundation" on BioPortfolio

We have published hundreds of The Bachmann-Strauss Dystonia and Parkinson Foundation news stories on BioPortfolio along with dozens of The Bachmann-Strauss Dystonia and Parkinson Foundation Clinical Trials and PubMed Articles about The Bachmann-Strauss Dystonia and Parkinson Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Bachmann-Strauss Dystonia and Parkinson Foundation Companies in our database. You can also find out about relevant The Bachmann-Strauss Dystonia and Parkinson Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record